MARKET

VIVE

VIVE

Viveve Med Inc
NASDAQ
0.4092
-0.0098
-2.34%
Closed 16:00 12/02 EST
OPEN
0.4300
PREV CLOSE
0.4190
HIGH
0.4300
LOW
0.3828
VOLUME
30.48K
TURNOVER
6.56K
52 WEEK HIGH
1.650
52 WEEK LOW
0.3828
MARKET CAP
4.39M
P/E (TTM)
-0.1546
1D
5D
1M
3M
1Y
5Y
BRIEF-Viveve Medical Receives Notice Of Delisting From Nasdaq
Reuters · 21h ago
BRIEF-Viveve Announces Issuance Of Second U.S. Method Patent For Treating Female Stress Urinary Incontinence
Reuters · 2d ago
BRIEF-Viveve Medical Inc Receives Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Reuters · 11/23 21:26
Viveve Medical Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues Lag
Viveve Medical ( NASDAQ:VIVE ) Third Quarter 2022 Results Key Financial Results Revenue: US$1.68m (up 4.2% from 3Q...
Simply Wall St. · 11/13 12:56
BRIEF-Viveve Medical Inc Reports Quarterly Loss Per Share Of $0.59 - Filing
Reuters · 11/10 22:19
Viveve Medical GAAP EPS of -$0.59 beats by $0.07, revenue of $17M beats by $15.29M
Seekingalpha · 11/10 21:44
Viveve Medical Q3 EPS $(0.59) Beats $(0.66) Estimate, Sales $1.68M Miss $1.70M Estimate
Benzinga · 11/10 21:17
Viveve Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's health and the treatment of female stress urinary incontinence (SUI), today reported financial results for the quarter ended September 30, 2022, and will provide a corporat...
ACCESSWIRE · 11/10 21:02
More
About VIVE
Viveve Medical, Inc. designs, develops, manufactures, and markets a platform medical technology, Cryogen-cooled Monopolar Radiofrequency (CMRF). The Company's CMRF technology is delivered through a radiofrequency (RF) generator, handpiece and treatment tip, that collectively, is referred to as the Viveve System. The Viveve System is marketed for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence (SUI), which is known as Viveve treatment. The Viveve System uses a method of delivering monopolar radiofrequency (RF) energy for treating tissue, such as Monopolar Radiofrequency Energy. The Viveve System also uses a cryogen surface cooling that enables volumetric heating of vaginal tissue. The Viveve System also uses a proprietary, controlled cryogen surface cooling that enables deep volumetric heating of vaginal tissue. The Company's subsidiary includes Viveve, Inc. and Viveve BV.

Webull offers kinds of Viveve Medical Inc stock information, including NASDAQ:VIVE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VIVE stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading VIVE stock methods without spending real money on the virtual paper trading platform.